Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal calcitonin added to standard treatment for frozen shoulder
IRCT20220523054971N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of TBRIA in adhesive capsulitis (AC) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Improvement of pain and range of motion. Started Dec 2021; status: completed.
02
Drugs
TBRIA
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on IRCT20220523054971N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220523054971N1.